Pharma | Pharmaceutical industry | News | Healthcare

ESMO 2020

Write a comment

To strengthen the oncology portfolio, Merck collaborated with Seattle Genetics, and Gilead acquired

Write a comment

Novartis Beovu demonstrated non-inferiority vs. aflibercept in the PEP and superiority in SEP

Write a comment

MSVirtual2020: Novartis and Roche, two Swiss giants, presents robust trial results of their assets

Write a comment

Merck announced trial results of gefapixant in patients with refractory or unexplained chronic cough

Write a comment

FDA approved Trelegy Ellipta for asthma, GSK’s triple therapy is now available for asthma and COPD

Write a comment

Oxford vaccine trials were paused because of safety concerns; AZ said it’s ‘routine’

Write a comment

FDA approved Roche’s Gavreto for RET fusion-positive NSCLC

Write a comment

Gene therapy developer AveXis renamed as Novartis Gene Therapies

Write a comment

European Society of Cardiology Congress 2020

Write a comment

FDA extended emergency use authorization of Veklury to all hospitalized patients

Write a comment

Bayer submitted vericiguat for market authorization in China

Write a comment

Bayer’s Xofigo received approval for prostate cancer in China

Write a comment

FDA has provided emergency use authorization for Abbott’s easy-to-use COVID-19 antigen test

Write a comment

European Commission approved GSK’s Blenrep for relapsed and refractory multiple myeloma

Write a comment

AUGUST: NICE ASSESSMENT OUTCOMES

Write a comment

Novartis presented robust clinical trial data of asciminib for chronic myeloid leukemia

Write a comment

BMS announced to acquire Forbius, targets to strengthen oncology and fibrosis portfolio

Write a comment

FDA issued Emergency Use Authorization of Convalescent Plasma for COVID-19 treatment

Write a comment

Merck’s Keytruda received one more indication and dosage form approval in Japan

Write a comment

TGA approved Tukysa for breast cancer in Australia

Write a comment

Johnson and Johnson acquired Momenta Pharmaceuticals, aims to strength immunology profile

Johnson and Johnson announced that it will acquire Momenta Pharmaceuticals for an all cash transaction worth of $6.5 billion. Momenta Pha...

Write a comment

Amgen’s Kyprolis and Janssen’s Darzalex combination approved by the US FDA for multiple myeloma

Write a comment

AZ received one more approval in Japan, received approval of Imfinzi for SCLC

Write a comment